Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Atea Pharmaceuticals, Inc. (AVIR) Institutional Ownership & Insider Trading

125 institutions reported holding Atea Pharmaceuticals, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AVIRAtea Pharmaceuticals, Inc.Follow AVIR — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
324.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

125 institutions held 74.1% of the shares. Across filers that reported both quarters, shares held changed -1.1%.

Increased+43New+16Decreased-37Closed-18

Largest moves, shares (millions)

Acadian Asset Management+0.5MBlackRock+0.3MQuantinno Capital Management+0.2MJane Street Group-0.4MTwo Sigma Investments-0.4MIrenic Capital Management-0.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+1.0Sep 24-2.0Dec 24-3.4Mar 25-0.2Jun 25+1.1Sep 25+3.2Dec 25+3.7Mar 26-0.7Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2612559-1.1%43163718
Mar 2612760+7.2%3722389
Dec 2511057+6.7%2594110
Sep 2511154+2.0%3210366
Jun 2510653-0.4%3413278
Mar 2510353-6.0%3373510
Dec 2410456-3.5%3683014
Sep 2410758+2.1%36122710

Atea Pharmaceuticals, Inc. — questions

Who owns Atea Pharmaceuticals, Inc. stock?
125 institutions reported Atea Pharmaceuticals, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (15.0%), BlackRock, Inc. (10.9%), BML Capital Management, LLC (8.7%).

Every figure on this page comes from Atea Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.